R42 Group is a venture capital firm that specializes in deep science ventures, primarily focusing on artificial intelligence (AI), biotechnology, and technology sectors. The firm's strategy involves investing in early-stage companies, from pre-seed to growth, with a particular emphasis on the intersection of AI and longevity.
100% of their portfolio is in Healthcare. Their most common stage is series-c (100% of deals).
Portfolio
1
Fund Size
$16M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Healx | Series C | $47M | Aug 2024 |
Top Co-Investors
Atomico1 shared
Last updated: 4 May 2026